Trial Profile
Phase 1, Randomized Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Scilex Pharmaceuticals
- 07 Sep 2018 According to a Scilex Pharmaceuticals media release, data from this trial presented at PAINWeek 2018
- 08 Mar 2018 New trial record
- 28 Feb 2018 Results presented in a Sorrento Therapeutics Media Release.